Proton pump inhibitors and tuberculosis risk

Int J Tuberc Lung Dis. 2020 Mar 1;24(3):353-354. doi: 10.5588/ijtld.19.0629.

Authors

T A Yates¹, L A Tomlinson², I J Douglas²

Affiliations

¹ Department of Infectious Disease, Faculty of Medicine, Imperial College London, London.
² Electronic Health Records Group, London School of Hygiene & Tropical Medicine, London, UK, <email></email>, Email: [email protected].

PMID: 32228767
DOI: 10.5588/ijtld.19.0629

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Proton Pump Inhibitors* / adverse effects
Risk Factors
Tuberculosis* / drug therapy
Tuberculosis* / epidemiology

Substances

Proton Pump Inhibitors